SAM
Smithbridge Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,368
| Closed | -$3.4M | – | 125 |
|
|
2025
Q1 | $3.4M | Buy |
+5,368
| New | +$3.4M | 0.63% | 51 |
|
|
2024
Q3 | $6.1M | Buy |
5,806
+2,503
| +76% | +$2.63M | 1.05% | 33 |
|
|
2024
Q2 | $3.47M | Sell |
3,303
-572
| -15% | -$601K | 0.72% | 46 |
|
|
2024
Q1 | $3.73M | Sell |
3,875
-197
| -5% | -$190K | 0.77% | 49 |
|
|
2023
Q4 | $3.58M | Sell |
4,072
-12
| -0.3% | -$10.5K | 0.81% | 47 |
|
|
2023
Q3 | $3.36M | Sell |
4,084
-291
| -7% | -$239K | 0.83% | 44 |
|
|
2023
Q2 | $3.14M | Sell |
4,375
-47
| -1% | -$33.8K | 0.74% | 49 |
|
|
2023
Q1 | $3.63M | Buy |
4,422
+146
| +3% | +$120K | 0.91% | 42 |
|
|
2022
Q4 | $3.09M | Buy |
+4,276
| New | +$3.09M | 0.82% | 49 |
|